echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Hengrui Pharmaceutical hydrochloric acid right metamidin sodium chloride infusion supplement application has been provisionally approved by the U.S. FDA

    Hengrui Pharmaceutical hydrochloric acid right metamidin sodium chloride infusion supplement application has been provisionally approved by the U.S. FDA

    • Last Update: 2020-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    recently, HengruiPharmaceutical(http://issued a notice that it has received anotice from theFDA (http://company(http://to the U.SFDA on the supplementary application for hydrochloric acid right metastinitin sodium chloride infusion has been provisionally approvedabout hydrochloric acid right metamidin sodium chloride infusionhydrochloric acid right metamidin sodium chloride infusion is a relatively selective alpha 2-adrenaline receptor agonist, suitable for the sedation of non-intubated patients before or during surgerysodium chloride infusion sodium hydrochloric acid, developed by Hospira Inc., was first approved in the United States in 2013 under the name Ofsterexdata show that in 2017, global sales of sodium hydrochloric acid right metastinated sodium chloride infusions were about $157 million, and U.Ssales were about $152 millionalso said that to date, Hengrui Pharmaceuticals has invested about Rmb34.45m in research and development in the's product(http://related information
    drug(http://name: hydrochloric acid right metamidin sodium chloride infusiondosage form: injectionspecifications: 80mcg/20mL, 200mcg/50mL and 400mcg/100mL
    Applicant: Jiangsu Hengrui Pharmaceutical Co., LtdANDA: 209065/S-002
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.